TargetRx, Inc.’s LaunchAdvantage Offers Critical Insight for Successful Drug Introductions

HORSHAM, Pa.--(BUSINESS WIRE)--With the impending “patent cliff,” it is more critical than ever to effectively bring new products to market. Pharmaceutical companies need to be armed with powerful insights to make the right decisions when launching new drugs and indications, assessing licensing and co-promotion opportunities and effectively managing their pipelines. In the past, brand teams have been challenged to accurately predict new drug potential and adoption because they have had to rely on a mix of traditional market research, prescribing histories and past experience. Now, TargetRx’s LaunchAdvantageSM is the first solution built for today’s health care market that accurately predicts what physicians will actually prescribe versus what they say they will prescribe – providing reliable forecasts that drive optimal resource allocation, effective messaging and positioning and ultimately, successful drug launches.